Dr. West on FDA Approval of Frontline Alectinib in ALK+ NSCLC OncLive 0:55 7 years ago 124 Далее Скачать
Dr. West on FDA Approval of Frontline Osimertinib in EGFR+ NSCLC OncLive 3:14 7 years ago 216 Далее Скачать
Copy of Dr. West on FDA Approval of Frontline Osimertinib in EGFR+ NSCLC OncLive 0:40 6 years ago 39 Далее Скачать
FDA D.I.S.C.O.: Two approvals for ALK-positive non-small cell lung cancer U.S. Food and Drug Administration 9:00 8 months ago 249 Далее Скачать
Dr. Drilon on the Safety Profile of Brigatinib in ALK+ NSCLC OncLive 1:38 4 years ago 153 Далее Скачать
Brigatinib at Disease Progression of ALK-Rearranged NSCLC Targeted Oncology 5:19 7 years ago 225 Далее Скачать
Approval of Alunbrig Offers Another Option for ALK Positive NSCLC, But Further Research Is Needed curetoday 3:44 4 years ago 419 Далее Скачать
Brigatinib for NSCLC, latest research and overcoming complications ecancer 4:28 4 years ago 171 Далее Скачать
